Autologous Stem Cell Transplant Improves Depth of Response and Outcomes in African American Patients When Compared With Caucasian Patients

There appears to be stark disparity in the incidence of multiple myeloma (MM) in the African American (AA) population (2-3 times higher) compared with Caucasians (C) [SEER 1975-2008 Data]. The AA pts appear to have lower incidence of high risk cytogenetics [Greenberg G et al, Blood Cancer J 2015] and the outcomes have not improved in the novel era therapy compared to C pts [Ailawahdi S et al, Blood Cancer J 2016]. We prospectively examined newly diagnosed transplant eligible MM pts at our center for outcomes.